CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone

NCT00401856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Cardiomyopathy

Interventions

DRUG: Eplerenone
DRUG: Placebo

Sponsor

Royal Brompton & Harefield NHS Foundation Trust